Financial insights of ADVM

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2024-09-30	2024-06-30
License revenue	0	-	1,000	-
Research and development	38,913	37,125	20,439	17,097
General and administrative	9,110	12,730	9,782	3,785
Total operating expenses	48,023	49,855	30,221	20,882
Operating loss	-48,023	-49,855	-29,221	-20,882
Other income, net	-	-	2,087	2,406
Net loss before income taxes	-	-	-27,134	-18,476
Other income, net	371	664	-	-
Net loss	-47,652	-49,191	-27,134	-18,476
Net unrealized gain (loss) on marketable securities	5	-	-	-
Foreign currency translation adjustment	6	18	16	10
Net unrealized loss on marketable securities	-	-11	241	-2
Comprehensive loss	-47,641	-49,184	-26,877	-18,468

Net loss per share basic (in usd per share)	-2.03	-2.34	-1.3	-0.89
Net loss per share diluted (in usd per share)	-2.03	-2.34	-1.3	-0.89
Weighted-average common shares used to compute net loss per share - basic (in shares)	23,487,000	21,010,000	20,876,000	20,852,000
Weighted-average common shares used to compute net loss per share - diluted (in shares)	23,487,000	21,010,000	20,876,000	20,852,000